GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,064,000 | +0.7% | 47,377 | +2.0% | 0.04% | +5.7% |
| Q4 2021 | $2,049,000 | +14.0% | 46,466 | -1.2% | 0.04% | +6.1% |
| Q3 2021 | $1,797,000 | -4.7% | 47,035 | -0.7% | 0.03% | -2.9% |
| Q2 2021 | $1,886,000 | +9.0% | 47,362 | -2.3% | 0.03% | +3.0% |
| Q1 2021 | $1,730,000 | +15.9% | 48,470 | +19.4% | 0.03% | +10.0% |
| Q4 2020 | $1,493,000 | -8.6% | 40,578 | -6.5% | 0.03% | -23.1% |
| Q3 2020 | $1,633,000 | -3.1% | 43,396 | +5.0% | 0.04% | -7.1% |
| Q2 2020 | $1,686,000 | +2.3% | 41,341 | -4.9% | 0.04% | -16.0% |
| Q1 2020 | $1,648,000 | -2.5% | 43,485 | +20.9% | 0.05% | +35.1% |
| Q4 2019 | $1,690,000 | +8.1% | 35,956 | -1.9% | 0.04% | 0.0% |
| Q3 2019 | $1,564,000 | -8.4% | 36,639 | -14.1% | 0.04% | -7.5% |
| Q2 2019 | $1,708,000 | -6.5% | 42,677 | -2.4% | 0.04% | -2.4% |
| Q1 2019 | $1,827,000 | +9.7% | 43,721 | +0.3% | 0.04% | -4.7% |
| Q4 2018 | $1,665,000 | +0.1% | 43,573 | +5.3% | 0.04% | +22.9% |
| Q3 2018 | $1,663,000 | -7.5% | 41,393 | -7.1% | 0.04% | -5.4% |
| Q2 2018 | $1,797,000 | +2.7% | 44,580 | -0.5% | 0.04% | +8.8% |
| Q1 2018 | $1,750,000 | +7.4% | 44,795 | -2.5% | 0.03% | +9.7% |
| Q4 2017 | $1,630,000 | -14.3% | 45,964 | -1.9% | 0.03% | -11.4% |
| Q3 2017 | $1,902,000 | -0.8% | 46,841 | +5.4% | 0.04% | -5.4% |
| Q2 2017 | $1,917,000 | +3.6% | 44,457 | +1.3% | 0.04% | +5.7% |
| Q1 2017 | $1,851,000 | +6.8% | 43,895 | -2.5% | 0.04% | 0.0% |
| Q4 2016 | $1,733,000 | -16.1% | 45,010 | -6.1% | 0.04% | -14.6% |
| Q3 2016 | $2,066,000 | -1.9% | 47,910 | -1.4% | 0.04% | -8.9% |
| Q2 2016 | $2,106,000 | +6.9% | 48,597 | +0.0% | 0.04% | +7.1% |
| Q1 2016 | $1,970,000 | +0.2% | 48,591 | -0.3% | 0.04% | +2.4% |
| Q4 2015 | $1,966,000 | +7.3% | 48,730 | +2.2% | 0.04% | 0.0% |
| Q3 2015 | $1,833,000 | -7.8% | 47,676 | -0.1% | 0.04% | +10.8% |
| Q2 2015 | $1,988,000 | -4.3% | 47,728 | +6.0% | 0.04% | -5.1% |
| Q1 2015 | $2,078,000 | +7.7% | 45,029 | -0.3% | 0.04% | +2.6% |
| Q4 2014 | $1,929,000 | -7.6% | 45,142 | -0.6% | 0.04% | -11.6% |
| Q3 2014 | $2,088,000 | +0.6% | 45,417 | +17.0% | 0.04% | +4.9% |
| Q2 2014 | $2,076,000 | -1.3% | 38,821 | -1.4% | 0.04% | 0.0% |
| Q1 2014 | $2,104,000 | +15.2% | 39,370 | +15.1% | 0.04% | +13.9% |
| Q4 2013 | $1,827,000 | +0.8% | 34,217 | -5.3% | 0.04% | -5.3% |
| Q3 2013 | $1,813,000 | -4.8% | 36,145 | -5.2% | 0.04% | -11.6% |
| Q2 2013 | $1,904,000 | – | 38,111 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |